Citation Tools

Download PDFPDF

Short report
Tocilizumab, but not dexamethasone, prevents CRS without affecting antitumor activity of bispecific antibodies

Download to a citation manager

Cite this article as:
Kauer J, Hörner S, Osburg L, et al
Tocilizumab, but not dexamethasone, prevents CRS without affecting antitumor activity of bispecific antibodies